Style Guide for DMJ Manuscripts

The title of the manuscript should be no longer than 20 English words.

short running title less than 50 characters

First Author1, Second Author2

Endocrinology and Metabolism, Department of Internal Medicine, University

College of Medicine, City, Country

Corresponding author: Name (http://orcid.org/0000-0000-0000-0000*)

Department of , University College of Medicine, Street Address, City, Postcode,

Country

E-mail:

*Open researcher and contributor IDs (ORCID) are recommended for all authors. To receive

ORCID, authors should register on the ORCID website available from: https://orcid.org/.

Word count: (text only)

Number of figures and tables:

1
Abstract

<Review article>

A review article should include an abstract not exceeding 200 words

<Original article>

Background, Methods, Results and Conclusion.

The abstract must not exceed 250 words.

<Brief report> 150 words maximum

<Short communication> 180 words maximum

Keywords: Term 1; Term 2; Term 3 (3 to 10, keywords should be found in MeSH terms

of the Index Medicus https://www.nlm.nih.gov/mesh/MBrowser.html)

2
Main text

<Review article> No limit

<Original article>

Introduction, Methods, Results, Discussion

Original articles should be no more than 4,000 words (excluding abstract, references, figure or

table legends)

<Brief report> The total manuscript length should not exceed 1,200 words, excluding references

and abstract.

<Short communication> The total manuscript length should not exceed 1,500 words, excluding

references and abstract.

INTRODUCTION

It is recommended that the introduction includes ‘general and specific background’,

‘debating issue’, and ‘specific purpose of this study’.

METHODS

Describe materials and methods under subtitles.

Give full information of instruments or reagents including manufacturers, city, and country.

Introduce methods of statistics.

If there are statistics and ethics issues in this study, they should be described as separate

paragraphs at the end of this section.

3
Statistical analysis

All statistical analyses were performed using …..

Ethics statement

(Example for clinical study)

The present study protocol was reviewed and approved by the Institutional Review Board of

PPP National University College of Medicine (approval No. 2020001). Informed consent was

submitted by all subjects when they were enrolled.

(Example for animal study)

The procedures used and the care of animals were approved by the Institutional Animal Care

and Use Committee in xxx University (approval No. 2020002).

(Example for clinical trials)

This is a randomized clinical trial on the second phase, registered at the Clinical Research

Information Service (CRIS, http://cris.nih.go.kr), number KCT0002018. Or other international

registration is acceptable.

RESULTS

Describe results under subtitles.

Prepare Tables or Figures for data presentation.

Avoid duplicated presentation of results in Tables and Figures.

DISCUSSION

Introduce and discuss the findings and their significance and meaning.

Include clinical or biomedical significance of this study.

Make summary or conclusion at the end of discussion.

4
CONFLICT OF INTEREST

No potential conflict of interest relevant to this article was reported.

AUTHOR CONTRIBUTIONS (Use CRediT terms)

Conception or design: X.Y.Z.

Acquisition, analysis, or interpretation of data: X.Y.Z.

Drafting the work or revising: X.Y.Z.

Final approval of the manuscript: X.Y.Z.

ORCID

First Author (http://orcid.org/0000-0000-0000-0000)

Corresponding author (http://orcid.org/0000-0000-0000-0000)

FUNDING STATEMENT

Describe the sources of funding that have supported the work. Please include relevant grant numbers and

the URL of any funder’s website. Also, describe the role of any sponsors or funders. If they had no role,

include this sentence at the end of your statement: “The funders had no role in study design, data

collection and analysis, decision to publish, or preparation of the manuscript.”

ACKNOWLEDGMENTS

Any persons that contributed to the study or the manuscript, but not meeting the requirements of an

authorship could be placed here. If you do not have anyone to acknowledge, please write “Not

applicable” in this section.

5
REFERENCES

<Review article> The number of references should not exceed 150.

<Original article> No more than 50 references

<Brief report> A maximum of 20 references

<Short communication> A maximum of 20 references

The order should be described as follows; authors’ names (list the first six authors and add “et al.”), title,

journal name, the year, volume, and page numbers.

>> Inzucchi SE, Maggs DG, Spollett GR, Page SL, Rife FS, Walton V, et al. Efficacy and metabolic

effects of metformin and troglitazone in type II diabetes mellitus. N Engl J Med 1998;338:867-72.

6
TABLES & FIGURE

<Original article> 6 figures or tables.

<Brief report> 2 figures or tables.

<Short communication> 2 figures or tables.

Table 1. Sample Table Title

Heading 1 Heading 2

Subheading 1-2 Subheading 1-1 Subheading 2-1 Subheading 2-2

Characteristic 1 44.2±6.5 0.075 44.2±6.5 0.075

Characteristic 2 23.1±2.5 <0.01a 23.1±2.5 <0.01

Characteristic 3 74.7±9.6 <0.01b 74.7±9.6 <0.01

Define abbreviation.
a
Footnote symbols should be marked with small alphabet letters (a, b, c… ).

FIGURE LEGENDS

Fig. 1. Figures Number with Arabic numerals in the order mentioned in the text. Figure

parts should be denoted by capital letters (Fig. 1A). Abbreviations used within the

figure should be explained.

Details in the Instructions to Authors (https://www.e-dmj.org/)